Hyperglycaemia and the SOAR stroke score in predicting mortality

Stephen McCall; Turkiah A. Alanazi; Allan B. Clark; Stanley D. Musgrave; Joao H. Bettencourt-Silva; Max O. Bachmann; Anthony K Metcalf; Kristian M. Bowles; Mamas A. Mamas; John F. Potter; Phyo K. Myint

doi:10.1177/1479164117743034

Hyperglycaemia and the SOAR stroke score in predicting mortality

Stephen McCall, Turkiah A. Alanazi, Allan B. Clark, Stanley D. Musgrave, Joao H. Bettencourt-Silva, Max O. Bachmann, Anthony K Metcalf, Kristian M. Bowles, Mamas A. Mamas, John F. Potter, Phyo K. Myint

Research output: Contribution to journal › Article › peer-review

6 Citations (Scopus)

6 Downloads (Pure)

Abstract

Background: We assessed the association between admission blood glucose levels and acute stroke mortality and examined if there was any incremental value of adding glucose status to the validated acute stroke mortality predictor - the SOAR score. Methods: Data from Norfolk and Norwich University Hospital Stroke & TIA register (20032013) and Anglia Stroke Clinical Network Evaluation Study (2009-2012) were analysed. Multivariable analysis assessed the association between admission blood glucose levels with inpatient and 7-day mortality. The prognostic ability of the SOAR score was then compared with the SOAR with glucose score(SOAR-G). Results: A total of 5,575 acute stroke patients(ischaemic stroke 89.2%), with mean age(sd) of 76.97±11.88 years were included. Both borderline hyperglycaemia (7.9-11.0mmol/L) and hyperglycaemia (>11.0mmol/L) when compared to normoglycaemia (4.0-7.8mmol/L), were associated with both 7-day and inpatient mortality after controlling for sex, age, OCSP classification and pre-stroke modified Rankin score. Both the SOAR stroke score and SOAR G were good predictors of inpatient stroke mortality [AUC 0.82(95%CI:0.81-0.84) and 0.83(95%CI:0.81-0.84)], respectively. These scores were also good at predicting outcomes in both patients with and without diabetes. Conclusions: High blood glucose levels at admission were associated with worse acute stroke mortality outcomes. The constituents of the SOAR stroke score were good at predicting mortality after stroke.

Original language	English
Pages (from-to)	114-121
Number of pages	8
Journal	Diabetes and Vascular Disease Research
Volume	15
Issue number	2
Early online date	29 Nov 2017
DOIs	https://doi.org/10.1177/1479164117743034
Publication status	Published - 1 Mar 2018

Bibliographical note

Acknowledgements
S.J.M. and T.A.A. are joint first authors. P.K.M. is the PI of both NNUSTR and ASCNES, and conceived the idea; S.D.M. and J.H.B-.S. performed data linkages; S.J.M. and T.A.A. did literature search, and cleaned and analysed the data under supervision of A.B.C.; J.F.P.D.M., M.O.B. and A.K.M. are co-I of ASCNES, and J.F.P.D.M., K.M.B. and A.K.M. are co-I of NNUSTR; and S.J.M. and P.K.M. drafted the manuscript. All authors contributed in writing the paper. P.K.M. is the guarantor. The authors gratefully acknowledge the data teams of the eight NHS Trusts which made up the ASCNES and the data team at the Norfolk and Norwich NHS Foundation Trust.

Funding
The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: The authors would like to acknowledge the funders of the Anglia Stroke Clinical Network Evaluation Study (ASCNES) and the Norfolk and Norwich Stroke and TIA Register. ASCNES is funded by the National Institute for Health Research (NIHR) Research for Patient Benefit Programme (PB-PG-1208-18240). This work presents independent research funded by the NIHR under its Research for Patient Benefit (RfPB) programme (grant reference no. PB-PG-1208-18240). The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health. The NNUH stroke and TIA register is maintained by the NNUH NHS Foundation Trust Stroke Services, and data management for this study is supported by the NNUH Research and Development Department through Research Capability Funds.

Keywords

Hyperglycaemia
Prognostic score
Stroke mortality

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1177/1479164117743034Licence: Unspecified

Accepted Manuscript
Copyright © The Author(s) 2017. Reprinted by permission of SAGE Publications.
Accepted author manuscript, 468 KBLicence: Other

Cite this

@article{2c81b4c5fbd24ea39b1a7622c7a9e6ba,

title = "Hyperglycaemia and the SOAR stroke score in predicting mortality",

abstract = "Background: We assessed the association between admission blood glucose levels and acute stroke mortality and examined if there was any incremental value of adding glucose status to the validated acute stroke mortality predictor - the SOAR score. Methods: Data from Norfolk and Norwich University Hospital Stroke & TIA register (20032013) and Anglia Stroke Clinical Network Evaluation Study (2009-2012) were analysed. Multivariable analysis assessed the association between admission blood glucose levels with inpatient and 7-day mortality. The prognostic ability of the SOAR score was then compared with the SOAR with glucose score(SOAR-G). Results: A total of 5,575 acute stroke patients(ischaemic stroke 89.2%), with mean age(sd) of 76.97±11.88 years were included. Both borderline hyperglycaemia (7.9-11.0mmol/L) and hyperglycaemia (>11.0mmol/L) when compared to normoglycaemia (4.0-7.8mmol/L), were associated with both 7-day and inpatient mortality after controlling for sex, age, OCSP classification and pre-stroke modified Rankin score. Both the SOAR stroke score and SOAR G were good predictors of inpatient stroke mortality [AUC 0.82(95%CI:0.81-0.84) and 0.83(95%CI:0.81-0.84)], respectively. These scores were also good at predicting outcomes in both patients with and without diabetes. Conclusions: High blood glucose levels at admission were associated with worse acute stroke mortality outcomes. The constituents of the SOAR stroke score were good at predicting mortality after stroke. ",

keywords = "Hyperglycaemia, Prognostic score, Stroke mortality",

author = "Stephen McCall and Alanazi, {Turkiah A.} and Clark, {Allan B.} and Musgrave, {Stanley D.} and Bettencourt-Silva, {Joao H.} and Bachmann, {Max O.} and Metcalf, {Anthony K} and Bowles, {Kristian M.} and Mamas, {Mamas A.} and Potter, {John F.} and Myint, {Phyo K.}",

note = "Acknowledgements S.J.M. and T.A.A. are joint first authors. P.K.M. is the PI of both NNUSTR and ASCNES, and conceived the idea; S.D.M. and J.H.B-.S. performed data linkages; S.J.M. and T.A.A. did literature search, and cleaned and analysed the data under supervision of A.B.C.; J.F.P.D.M., M.O.B. and A.K.M. are co-I of ASCNES, and J.F.P.D.M., K.M.B. and A.K.M. are co-I of NNUSTR; and S.J.M. and P.K.M. drafted the manuscript. All authors contributed in writing the paper. P.K.M. is the guarantor. The authors gratefully acknowledge the data teams of the eight NHS Trusts which made up the ASCNES and the data team at the Norfolk and Norwich NHS Foundation Trust. Funding The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: The authors would like to acknowledge the funders of the Anglia Stroke Clinical Network Evaluation Study (ASCNES) and the Norfolk and Norwich Stroke and TIA Register. ASCNES is funded by the National Institute for Health Research (NIHR) Research for Patient Benefit Programme (PB-PG-1208-18240). This work presents independent research funded by the NIHR under its Research for Patient Benefit (RfPB) programme (grant reference no. PB-PG-1208-18240). The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health. The NNUH stroke and TIA register is maintained by the NNUH NHS Foundation Trust Stroke Services, and data management for this study is supported by the NNUH Research and Development Department through Research Capability Funds.",

year = "2018",

month = mar,

day = "1",

doi = "10.1177/1479164117743034",

language = "English",

volume = "15",

pages = "114--121",

journal = "Diabetes and Vascular Disease Research",

issn = "1479-1641",

publisher = "SAGE Publications Ltd",

number = "2",

}

TY - JOUR

T1 - Hyperglycaemia and the SOAR stroke score in predicting mortality

AU - McCall, Stephen

AU - Alanazi, Turkiah A.

AU - Clark, Allan B.

AU - Musgrave, Stanley D.

AU - Bettencourt-Silva, Joao H.

AU - Bachmann, Max O.

AU - Metcalf, Anthony K

AU - Bowles, Kristian M.

AU - Mamas, Mamas A.

AU - Potter, John F.

AU - Myint, Phyo K.

N1 - Acknowledgements S.J.M. and T.A.A. are joint first authors. P.K.M. is the PI of both NNUSTR and ASCNES, and conceived the idea; S.D.M. and J.H.B-.S. performed data linkages; S.J.M. and T.A.A. did literature search, and cleaned and analysed the data under supervision of A.B.C.; J.F.P.D.M., M.O.B. and A.K.M. are co-I of ASCNES, and J.F.P.D.M., K.M.B. and A.K.M. are co-I of NNUSTR; and S.J.M. and P.K.M. drafted the manuscript. All authors contributed in writing the paper. P.K.M. is the guarantor. The authors gratefully acknowledge the data teams of the eight NHS Trusts which made up the ASCNES and the data team at the Norfolk and Norwich NHS Foundation Trust. Funding The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: The authors would like to acknowledge the funders of the Anglia Stroke Clinical Network Evaluation Study (ASCNES) and the Norfolk and Norwich Stroke and TIA Register. ASCNES is funded by the National Institute for Health Research (NIHR) Research for Patient Benefit Programme (PB-PG-1208-18240). This work presents independent research funded by the NIHR under its Research for Patient Benefit (RfPB) programme (grant reference no. PB-PG-1208-18240). The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health. The NNUH stroke and TIA register is maintained by the NNUH NHS Foundation Trust Stroke Services, and data management for this study is supported by the NNUH Research and Development Department through Research Capability Funds.

PY - 2018/3/1

Y1 - 2018/3/1

N2 - Background: We assessed the association between admission blood glucose levels and acute stroke mortality and examined if there was any incremental value of adding glucose status to the validated acute stroke mortality predictor - the SOAR score. Methods: Data from Norfolk and Norwich University Hospital Stroke & TIA register (20032013) and Anglia Stroke Clinical Network Evaluation Study (2009-2012) were analysed. Multivariable analysis assessed the association between admission blood glucose levels with inpatient and 7-day mortality. The prognostic ability of the SOAR score was then compared with the SOAR with glucose score(SOAR-G). Results: A total of 5,575 acute stroke patients(ischaemic stroke 89.2%), with mean age(sd) of 76.97±11.88 years were included. Both borderline hyperglycaemia (7.9-11.0mmol/L) and hyperglycaemia (>11.0mmol/L) when compared to normoglycaemia (4.0-7.8mmol/L), were associated with both 7-day and inpatient mortality after controlling for sex, age, OCSP classification and pre-stroke modified Rankin score. Both the SOAR stroke score and SOAR G were good predictors of inpatient stroke mortality [AUC 0.82(95%CI:0.81-0.84) and 0.83(95%CI:0.81-0.84)], respectively. These scores were also good at predicting outcomes in both patients with and without diabetes. Conclusions: High blood glucose levels at admission were associated with worse acute stroke mortality outcomes. The constituents of the SOAR stroke score were good at predicting mortality after stroke.

AB - Background: We assessed the association between admission blood glucose levels and acute stroke mortality and examined if there was any incremental value of adding glucose status to the validated acute stroke mortality predictor - the SOAR score. Methods: Data from Norfolk and Norwich University Hospital Stroke & TIA register (20032013) and Anglia Stroke Clinical Network Evaluation Study (2009-2012) were analysed. Multivariable analysis assessed the association between admission blood glucose levels with inpatient and 7-day mortality. The prognostic ability of the SOAR score was then compared with the SOAR with glucose score(SOAR-G). Results: A total of 5,575 acute stroke patients(ischaemic stroke 89.2%), with mean age(sd) of 76.97±11.88 years were included. Both borderline hyperglycaemia (7.9-11.0mmol/L) and hyperglycaemia (>11.0mmol/L) when compared to normoglycaemia (4.0-7.8mmol/L), were associated with both 7-day and inpatient mortality after controlling for sex, age, OCSP classification and pre-stroke modified Rankin score. Both the SOAR stroke score and SOAR G were good predictors of inpatient stroke mortality [AUC 0.82(95%CI:0.81-0.84) and 0.83(95%CI:0.81-0.84)], respectively. These scores were also good at predicting outcomes in both patients with and without diabetes. Conclusions: High blood glucose levels at admission were associated with worse acute stroke mortality outcomes. The constituents of the SOAR stroke score were good at predicting mortality after stroke.

KW - Hyperglycaemia

KW - Prognostic score

KW - Stroke mortality

U2 - 10.1177/1479164117743034

DO - 10.1177/1479164117743034

M3 - Article

SN - 1479-1641

VL - 15

SP - 114

EP - 121

JO - Diabetes and Vascular Disease Research

JF - Diabetes and Vascular Disease Research

IS - 2

ER -

Hyperglycaemia and the SOAR stroke score in predicting mortality

Abstract

Bibliographical note

Keywords

UN SDGs

Access to Document

Fingerprint

Cite this